Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Mobius Interactive Ltd., Leading iGaming Provider Partner to Build Worldwide Network of Dedicated Gamers

Mobius partners with UltraPlay to enhance customer engagement UltraPlay at forefront of iGaming industry, provides widest eSports betting coverage in industry Partnership is clear indication of Mobius’s strong position coming straight out of gate Mobius Interactive, an online gaming operator providing a variety of unique offerings catering to diverse demographic groups, has partnered with UltraPlay, […]

Trxade Group, Inc. (NASDAQ: MEDS) Showcases Prescription Affordability Efforts During Virtual Investor Summit

Pharmaceutical industry services provider Trxade Group Inc. presented an overview of the company’s structure and strategy at this month’s LD 500 invitational microcap investor summit The investor summit was a virtual gathering place during the ongoing pandemic, providing brand and industry information through webcasts to more than 20,000 attendees representing hundreds of companies Trxade Group […]

Sharing Services Global Corp. (SHRG) in Ideal Position to Benefit as Direct-Sales Industry Posts Healthy Growth

World Federation of Direct Selling Associations reports healthy growth Wellness continues to be leader in U.S. space, where SHRG continues to attract customers, entrepreneurs with inclusive Blue Ocean strategy Strategy proves successful as reflected in robust fundamentals SHRG continues to post Sharing Services Global (OTCQB: SHRG), a diversified holding company specializing in the direct-selling industry […]

Pure Extract Technologies Inc. Sets Sights on Functional Mushroom Industry

Pure Extract Technologies focuses on extraction of volatile plant molecules Company has recently announced entry into functional mushroom market, providing extraction services Pure Extract applying for Natural Health Products site license with Health Canada, which will help ensure that high quality standards will be upheld while also lending Company sales entry into foreign markets Company […]

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary’s CIO Discusses Curing Cancer with AI on DojoLIVE! Interview

POAI subsidiary Helomics exec discusses the company’s quest to fight cancer Helomics tapping into the fast growing, billion-dollar AI in drug discovery market Pittsburgh-based company has been building foundational groundwork in cancer drug response profiling for two decades Helomics harnesses rich historic tumor data with the power of AI to test living tumor tissues Predictive […]

Cybin Corp. New CEO Set to Pave Path to Profitability, Grow IP Portfolio Organically

Cybin announces appointment of established pharma industry figure as new CEO Drysdale leverages 30 years of leadership, entrepreneurial experience in life-science space Announcement comes as Cybin sets out on path to profitability Cybin Corp., an innovative life science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, has announced the appointment of Mr. Doug Drysdale […]

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Reports Record Numbers, Ranks in Top-10 Nielsen Report

In its most recent SEC filings, WTER announced record first-quarter revenue of $14.2 million Alkaline88 ranked as 10th best-selling value-added water and third fastest-growing value-added water in Nielsen report WTER marks milestone by adding the largest food-service redistributor to its growing list of channel partners The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) continues its […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Sub-Licensee Partner Announces CRO for Phase 1 and Phase 2 Berubicin Trials in Poland

Poland trials will include the first ever Phase 1 trial for pediatric patients suffering from glioblastoma multiforme CNS Pharmaceuticals has made significant strides in its Berubicin manufacturing process due to its dual-track approach and expects to begin production of its drug candidate at Pharmaceuticals International during the third quarter of 2020 The Company’s CFO recently […]

 

From Our Blog

LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Marks a Strategic Inflection Point with $7,800,421 in Total Financing Following Closing of LIFE, Flow Through, and Final Hard Dollar Offering

January 9, 2026

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) is a Canadian gold exploration and development company advancing its district-scale Swanson Gold Project in Québec’s prolific Abitibi Gold Belt and progressing toward the near-term restart of gold production […]

Rotate your device 90° to view site.